ESA, INC. – Trademark Portfolio
Entity Type: 03
ESA, INC. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 14 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CORONA and LEADCARE. The owner is based in CHELMSFORD, MA.
22 ALPHA ROAD
CHELMSFORD, MA 01824
Showing of trademarks Trademarks
Trademark Classifications
ESA, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does ESA, INC. have?
ESA, INC. has 21 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 15 cancelled.
What trademark classes does ESA, INC. file in?
ESA, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ESA, INC.'s most well-known trademarks?
ESA, INC.'s registered trademark portfolio includes well-known marks such as CORONA and LEADCARE. These are among 2 currently registered trademarks in the portfolio.
What is ESA, INC.'s trademark registration success rate?
ESA, INC. has a 10% trademark registration rate, with 2 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.